These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 39269961
1. Lessons for future pandemics: Temporal evolution and rural-urban variations in the impacts of the COVID-19 on opioid use treatment. He Z, Heess JM, Young T, Lei Z. PLoS One; 2024; 19(9):e0310386. PubMed ID: 39269961 [Abstract] [Full Text] [Related]
2. Perceptions of individuals in treatment for substance use disorder during COVID-19: insight on mental health, sobriety, access to treatment, and telehealth. Bayers T, Strohmaier T, Shreffler J, Huecker M. J Addict Dis; 2022; 40(1):111-113. PubMed ID: 34296654 [Abstract] [Full Text] [Related]
3. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic. Jones CM, Shoff C, Hodges K, Blanco C, Losby JL, Ling SM, Compton WM. JAMA Psychiatry; 2022 Oct 01; 79(10):981-992. PubMed ID: 36044198 [Abstract] [Full Text] [Related]
4. Primary Care Providers' Experiences Treating Opioid Use Disorder Using Telehealth in the Height of the COVID-19 Pandemic. Marshall SA, Siebenmorgen LE, Youngen K, Borders T, Zaller N. J Prim Care Community Health; 2024 Oct 01; 15():21501319241246359. PubMed ID: 38600789 [Abstract] [Full Text] [Related]
5. Telehealth Utilization for Opioid Use Disorder: A Nationwide Analysis Before and After the COVID-19 Public Health Emergency Declaration. Lewis KN, Zhang D, Corrales G, Eswaran H, Hayes CJ, Gressler LE. Telemed J E Health; 2024 Jun 01; 30(7):e1980-e1989. PubMed ID: 38621153 [No Abstract] [Full Text] [Related]
6. An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic. Hughes PM, Verrastro G, Fusco CW, Wilson CG, Ostrach B. J Rural Health; 2021 Jun 01; 37(3):467-472. PubMed ID: 33720447 [Abstract] [Full Text] [Related]
12. Leveraging Policy Changes Made in Response to COVID-19 to Advance Telehealth and Novel Treatment Approaches for People Who Use Opioids: Qualitative Perspectives From Two Rural North Carolina Counties. Chen H, Knettel BA, Macon Harrison L, Des Marais A, Nelli A, Campbell HA, Muhirwa A, McKellar MS, Gulur P, Guthrie S. N C Med J; 2023 Jul 01; 84(5):335-341. PubMed ID: 39312782 [Abstract] [Full Text] [Related]
13. Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic. Jones CM, Diallo MM, Vythilingam M, Schier JG, Eisenstat M, Compton WM. Drug Alcohol Depend; 2021 Aug 01; 225():108783. PubMed ID: 34049102 [Abstract] [Full Text] [Related]
14. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial. Hser YI, Ober AJ, Dopp AR, Lin C, Osterhage KP, Clingan SE, Mooney LJ, Curtis ME, Marsch LA, McLeman B, Hichborn E, Lester LS, Baldwin LM, Liu Y, Jacobs P, Saxon AJ. Addict Sci Clin Pract; 2021 Apr 20; 16(1):24. PubMed ID: 33879260 [Abstract] [Full Text] [Related]
16. Employing telehealth strategies for opioid addiction during COVID-19: implications for social work health care. Kim SH, Tesmer O. Soc Work Health Care; 2021 Aug 09; 60(6-7):499-508. PubMed ID: 34278979 [Abstract] [Full Text] [Related]
18. Co-Constructing a Community-Based Telemedicine Program for People With Opioid Use Disorder During the COVID-19 Pandemic: Lessons Learned and Implications for Future Service Delivery. Høj SB, de Montigny C, Chougar S, Léandre R, Beauchemin-Nadeau MÈ, Boyer-Legault G, Goyette A, Lamont SK, Bruneau J. JMIR Public Health Surveill; 2023 Jul 26; 9():e39236. PubMed ID: 37494097 [Abstract] [Full Text] [Related]